Holen Sie sich die Stockscreener-App
319.97
2.71%
8.43
Handel nachbörslich:
320.69
0.72
+0.23%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$311.54
Offen:
$311.91
24-Stunden-Volumen:
8.39M
Relative Volume:
0.81
Marktkapitalisierung:
$289.84B
Einnahmen:
$435.16B
Nettoeinkommen (Verlust:
$18.37B
KGV:
16.70
EPS:
19.1623
Netto-Cashflow:
$17.37B
1W Leistung:
-0.59%
1M Leistung:
-12.43%
6M Leistung:
+5.61%
1J Leistung:
-46.45%
1-Tages-Spanne:
$311.44
$323.83
1-Wochen-Bereich:
$304.53
$327.88
52-Wochen-Spanne:
$234.60
$622.83
Unitedhealth Group Inc Stock (UNH) Company Profile
Firmenname
Unitedhealth Group Inc
Sektor
Branche
Telefon
1-800-328-5979
Adresse
1 HEALTH DRIVE, EDEN PRAIRIE
Vergleichen Sie UNH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UNH
Unitedhealth Group Inc
|
319.97 | 282.20B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
78.03 | 96.53B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
278.09 | 72.02B | 268.22B | 6.55B | 7.44B | 22.67 |
|
ELV
Elevance Health Inc
|
321.73 | 69.78B | 194.82B | 5.53B | 3.77B | 24.45 |
|
HUM
Humana Inc
|
227.10 | 26.86B | 123.11B | 1.58B | 2.44B | 13.03 |
Unitedhealth Group Inc Stock (UNH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-07-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2025-07-30 | Bestätigt | Oppenheimer | Outperform |
| 2025-06-11 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-05-21 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2025-05-19 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-05-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-14 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2025-04-22 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-21 | Herabstufung | Argus | Buy → Hold |
| 2025-01-10 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-01-06 | Bestätigt | Truist | Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-07-17 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-17 | Bestätigt | RBC Capital Mkts | Outperform |
| 2024-06-05 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-04 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-12-18 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2023-10-16 | Hochstufung | UBS | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Bestätigt | UBS | Neutral |
| 2023-07-18 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-07-17 | Bestätigt | JP Morgan | Overweight |
| 2023-07-17 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-07-17 | Bestätigt | TD Cowen | Outperform |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-06-01 | Bestätigt | BofA Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-04-21 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Herabstufung | Argus | Buy → Hold |
| 2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-03-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-10-10 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-04-17 | Bestätigt | BofA/Merrill | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-09-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-06-11 | Eingeleitet | SunTrust | Buy |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-17 | Bestätigt | Citigroup | Buy |
| 2018-01-12 | Bestätigt | Evercore ISI | Outperform |
| 2018-01-03 | Eingeleitet | Goldman | Buy |
| 2017-07-19 | Bestätigt | Mizuho | Buy |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Unitedhealth Group Inc Aktie (UNH) Neueste Nachrichten
Is UnitedHealth Group (UNH) Undervalued After Recent Share Price Recovery? - simplywall.st
What Catalysts Could Shift the Narrative for UnitedHealth as Analyst Views Evolve? - Yahoo Finance Singapore
Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know - TradingView
UnitedHealth Appoints Scott Gottlieb as Independent Director - TipRanks
UnitedHealth Group (UNH) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
AI Analyst Downgrades UnitedHealth (UNH) Stock But Wall Street Isn’t Worried - TipRanks
UnitedHealth Stock: ‘Big,’ ‘Fat,’ and ‘Rich,’ or an Undervalued S&P 500 Buy Here? - Barchart.com
Healthcare Quality Management (QMS) Market Research and Global Forecast Report 2025-2030: Opportunities in Integration With Patient-Generated Health Data, & Voice and NLP for Quality Documentation - GlobeNewswire Inc.
With UnitedHealth Stock (UNH) Down Over 38%, Let’s Look at Who Owns It - TipRanks
Is UnitedHealth Group Now a Bargain After This Week’s 8.8% Drop? - simplywall.st
UnitedHealth: Buy Before The Buybacks Resume (NYSE:UNH) - Seeking Alpha
Former FDA Commissioner Scott Gottlieb joins UnitedHealth’s board - Healthcare Finance News
How Bad Can It Get For UnitedHealth? - Forbes
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
HSBC Adjusts Price Target on UnitedHealth Group to $280 From $260, Maintains Reduce Rating - MarketScreener
UnitedHealth price suffers from negative pressuresForecast today20-11-2025 - Economies.com
How UnitedHealth Group Incorporated (UNH) stock performs in easing cyclesTrade Ideas & Verified Stock Trade Ideas - newser.com
Trump’s former FDA commissioner joins board of UnitedHealth - HealthExec
UnitedHealth (UNH): Assessing Valuation After Recent Share Price Decline - Yahoo Finance
UnitedHealth is dropping a million seniors from Medicare Advantage as it aims to restore its ‘swagger’ - MSN
UnitedHealth Group Investors Get Crazy Bullish In Stunning About Face (UNH Stock) - AOL.com
Will UnitedHealth Group Incorporated (UNH) stock beat growth indexes2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com
UnitedHealth Group Stock Prediction: Where Analysts See the Stock Going by 2027 - TIKR.com
UnitedHealth Group Stock (UNH) Opinions on DOJ Investigation and Sentiment Shift - Quiver Quantitative
UnitedHealth adds former FDA commissioner Scott Gottlieb to board - Healthcare Dive
Opinion: UnitedHealth is dropping a million seniors from Medicare Advantage as it aims to restore its ‘swagger’ - MarketWatch
Is UnitedHealth Group (UNH) Trading at an Attractive Valuation? - Yahoo Finance
Why UnitedHealth Group Incorporated is moving todayBull Run & Weekly Top Gainers Trade List - newser.com
Why UnitedHealth Group Incorporated stock benefits from AI revolutionJuly 2025 Rallies & High Yield Stock Recommendations - newser.com
Why Is UnitedHealth Group Undervalued and Poised to Outperform Palantir? - NAI500
UnitedHealth Group Appoints Scott Gottlieb to its Board of Directors, Effective November 18, 2025 - MarketScreener
Scott Gottlieb to Join UnitedHealth Board of Directors - PharmExec.com
UnitedHealth Group falls 2.91%, after major investor reduces stake and bearish signals mount - Traders Union
Former FDA Commissioner Scott Gottlieb joins UnitedHealth Group's board - Fierce Healthcare
UnitedHealth names former US FDA chief Scott Gottlieb to its board - Reuters
How UnitedHealth Group Profits from Healthcare Operations - Investopedia
UnitedHealth Group Taps Former FDA Chief And Medicare Advisor To Board - Forbes
UnitedHealth adds former FDA commissioner Scott Gottlieb to director board - Seeking Alpha
What Could Ignite UNH Stock’s Next Major Rally? - Forbes
Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga
Dr. Scott Gottlieb Joins UnitedHealth (UNH) Board of Directors - GuruFocus
Former FDA commissioner Scott Gottlieb joins UnitedHealth board - Investing.com India
Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors - Business Wire
Is There Opportunity in UnitedHealth Group After a 36.5% Drop in 2025? - Yahoo Finance
UnitedHealth Group | History, Growth, & Controversies - Britannica
What Could Spark the UnitedHealth Stock's Next Big Move - Trefis
Jim Cramer Says "UnitedHealth Has Got A Lot of Good Things Going for It" - Finviz
Jim Cramer Says “UnitedHealth Has Got A Lot of Good Things Going for It” - Yahoo Finance
Nebraska AG’s Lawsuit Against Change Healthcare Survives Motion to Dismiss - The HIPAA Journal
UnitedHealth Group's Options: A Look at What the Big Money is Thinking - Benzinga
UnitedHealth Shares Defy Bullish Outlook with Steep Decline - AD HOC NEWS
Finanzdaten der Unitedhealth Group Inc-Aktie (UNH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):